No Data
No Data
No Data
Stocks in Play: Crescita Therapeutics Inc.
Crescita Therapeutics Introduces "World's Smallest Intradermal Delivery Device"
Crescita Therapeutics (CTX.TO), a company in the commercial dermatology market, on Wednesday said it has signed a distribution agreement with NanoPass Technologies, which develops and commercialises
Crescita Therapeutics Announces the Results of Its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Q1 Loss Widens, Revenue Rises
Crescita Therapeutics (CTX.TO), a Canadian dermatology company, on Wednesday reported a first-quarter net loss of $626,000, or $0.03 per share, wider than a loss of $273,000, or $0.01 per share, a yea
Crescita Therapeutics Brief: Q1 Revenue Was $4.996 Million
07:31 AM EDT, 05/08/2024 (MT Newswires) -- Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million
Crescita Reports Third Quarter 2023 Results